These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17882965)

  • 21. Oral absorption of ginsenoside Rb1 using in vitro and in vivo models.
    Han M; Sha X; Wu Y; Fang X
    Planta Med; 2006 Apr; 72(5):398-404. PubMed ID: 16557452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine.
    Baboota S; Al-Azaki A; Kohli K; Ali J; Dixit N; Shakeel F
    PDA J Pharm Sci Technol; 2007; 61(4):276-85. PubMed ID: 17933209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions.
    Junyaprasert VB; Boonme P; Songkro S; Krauel K; Rades T
    J Pharm Pharm Sci; 2007; 10(3):288-98. PubMed ID: 17727792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides.
    Constantinides PP; Scalart JP; Lancaster C; Marcello J; Marks G; Ellens H; Smith PL
    Pharm Res; 1994 Oct; 11(10):1385-90. PubMed ID: 7855039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro release of diclofenac diethylamine from caprylocaproyl macrogolglycerides based microemulsions.
    Djordjevic L; Primorac M; Stupar M
    Int J Pharm; 2005 May; 296(1-2):73-9. PubMed ID: 15885457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models.
    Han M; Fang XL
    Acta Pharmacol Sin; 2006 Apr; 27(4):499-505. PubMed ID: 16539852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro balanced sustained-release of Panax notoginseng saponins controlled with various matrix materials].
    Zhou X; Fu CM; He Y; Zhang JM; Liu HY
    Yao Xue Xue Bao; 2010 Apr; 45(4):505-9. PubMed ID: 21355219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of nano-emulsion formation by dilution of microemulsions.
    Solè I; Solans C; Maestro A; González C; Gutiérrez JM
    J Colloid Interface Sci; 2012 Jun; 376(1):133-9. PubMed ID: 22480397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal delivery of capsaicin derivative-sodium nonivamide acetate using microemulsions as vehicles.
    Huang YB; Lin YH; Lu TM; Wang RJ; Tsai YH; Wu PC
    Int J Pharm; 2008 Feb; 349(1-2):206-11. PubMed ID: 17766068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain distribution pharmacokinetics and integrated pharmacokinetics of Panax Notoginsenoside R1, Ginsenosides Rg1, Rb1, Re and Rd in rats after intranasal administration of Panax Notoginseng Saponins assessed by UPLC/MS/MS.
    Guo Q; Li P; Wang Z; Cheng Y; Wu H; Yang B; Du S; Lu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():264-71. PubMed ID: 25203723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction.
    Ge S; Lin Y; Lu H; Li Q; He J; Chen B; Wu C; Xu Y
    Int J Pharm; 2014 Apr; 465(1-2):120-31. PubMed ID: 24530389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vivo distribution and pharmacokinetics of multiple effective components contained in Panax notoginseng saponins after intratympanic administration].
    Chen G; Mu L; Zhang X; Hou S; Nan H
    Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(13):1815-20. PubMed ID: 22032151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats.
    Liu H; Yang J; Du F; Gao X; Ma X; Huang Y; Xu F; Niu W; Wang F; Mao Y; Sun Y; Lu T; Liu C; Zhang B; Li C
    Drug Metab Dispos; 2009 Dec; 37(12):2290-8. PubMed ID: 19786509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and efficiency of brain targeting of ginsenosides Rg1 and Rb1 given as Nao-Qing microemulsion.
    Li T; Shu YJ; Cheng JY; Liang RC; Dian SN; Lv XX; Yang MQ; Huang SL; Chen G; Yang F
    Drug Dev Ind Pharm; 2015 Feb; 41(2):224-31. PubMed ID: 24237326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds.
    Araya H; Tomita M; Hayashi M
    Int J Pharm; 2005 Nov; 305(1-2):61-74. PubMed ID: 16219433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation of a cosurfactant-free O/W microemulsion using nonionic surfactant mixtures.
    Cho YH; Kim S; Bae EK; Mok CK; Park J
    J Food Sci; 2008 Apr; 73(3):E115-21. PubMed ID: 18387105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and evaluation of fexofenadine microemulsions for intranasal delivery.
    Piao HM; Balakrishnan P; Cho HJ; Kim H; Kim YS; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2010 Aug; 395(1-2):309-16. PubMed ID: 20635476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Release of nortriptyline hydrochloride from oil-water microemulsions.
    Moreno M; Frutos P; Ballesteros MP; Lastres JL; Castro D
    Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1623-7. PubMed ID: 11086887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Contribution of Increased Intestinal Permeability and Inhibited Deglycosylation of Ginsenoside Rb1 in the Intestinal Tract to the Enhancement of Ginsenoside Rb1 Exposure in Diabetic Rats after Oral Administration.
    Liu C; Hu M; Guo H; Zhang M; Zhang J; Li F; Zhong Z; Chen Y; Li Y; Xu P; Li J; Liu L; Liu X
    Drug Metab Dispos; 2015 Nov; 43(11):1702-10. PubMed ID: 26265741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal Delivery of Compounds with Different Lipophilicity and Molecular Weight from W/O Microemulsions Analyzed by UPLC-QTOF/ MS and LC-MS/MS.
    Lin H; Michniak-Kohn B; Xia Z; Xu L; Kang Q; Chen C; Ma S; Wu Q
    Curr Drug Deliv; 2018; 15(7):1009-1019. PubMed ID: 29268684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.